论文部分内容阅读
目的分析吉林省2009~2014年乙型肝炎疫苗(hepatitis B vaccines,Hep B)疑似预防接种异常反应(adverse events following immunization,AEFI)的发生特征,评价Hep B安全性及吉林省AEFI监测工作。方法通过全国AEFI监测信息管理系统,收集吉林省2009~2014年报告Hep B AEFI数据,采用描述性流行病学方法对相关数据进行分析。结果吉林省2009~2014年共报告Hep B AEFI 897例,报告发生率为159.11/100万剂次;男女性别比为1.09∶1;<1岁婴儿占88.85%;一般反应报告发生率为154.50/100万剂次,异常反应报告发生率为3.37/100万剂次;Hep B AEFI主要集中在接种后≤1 d。结论 Hep B具有较好的安全性,AEFI以一般反应和过敏反应为主。
Objective To analyze the occurrence of Hepatitis A virus (AEFI) in Hep B from 2009 to 2014 in Jilin Province and evaluate the safety of Hep B and AEFI surveillance in Jilin Province. Methods AEFI monitoring information management system was used to collect Hep B AEFI data from 2009 to 2014 in Jilin Province. Descriptive epidemiological methods were used to analyze the data. Results A total of 897 cases of Hep B AEFI were reported from 2009 to 2014 in Jilin Province, with a reported incidence of 159.11 / 1 million doses. The sex ratio was 1.09:1. Sex infants <1 year old accounted for 88.85%; general reaction rate was 154.50 / 1 million doses, the incidence of anomalous reactions reported 3.37 / 1 million doses; Hep B AEFI mainly concentrated after inoculation ≤ 1 d. Conclusion Hep B has good safety. AEFI is mainly based on general and allergic reactions.